Literature DB >> 19630821

Genetics of venous thrombosis.

F R Rosendaal1, P H Reitsma.   

Abstract

Venous thrombosis (deep vein thrombosis, pulmonary embolism) is a common and serious disorder, with genetic and acquired risk factors. The genetic risk factors can be subdivided in to those that are strong, moderate and weak. Strong risk factors are deficiencies of antithrombin, protein C and protein S. Moderately strong are factor V Leiden, prothrombin 20210A, non-O blood group and fibrinogen 10034T. There are many weak genetic risk factors, including fibrinogen, factor XIII and factor XI variants. Even for moderately strong risk factors (relative risks 2-5), the majority of carriers will never develop thrombosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19630821     DOI: 10.1111/j.1538-7836.2009.03394.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  69 in total

Review 1.  Acute pulmonary embolism. Part 1: epidemiology and diagnosis.

Authors:  Renée A Douma; Pieter W Kamphuisen; Harry R Büller
Journal:  Nat Rev Cardiol       Date:  2010-07-20       Impact factor: 32.419

2.  A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium.

Authors:  Weihong Tang; Martina Teichert; Daniel I Chasman; John A Heit; Pierre-Emmanuel Morange; Guo Li; Bruno H Ch Stricker; Paul M Ridker; Aaron R Folsom; Nicholas L Smith; Nathan Pankratz; Frank W Leebeek; Guillaume Paré; Mariza de Andrade; Christophe Tzourio; Bruce M Psaty; Saonli Basu; Rikje Ruiter; Lynda Rose; Sebastian M Armasu; Thomas Lumley; Susan R Heckbert; André G Uitterlinden; Mark Lathrop; Kenneth M Rice; Mary Cushman; Albert Hofman; Jean-Charles Lambert; Nicole L Glazer; James S Pankow; Jacqueline C Witteman; Philippe Amouyel; Joshua C Bis; Edwin G Bovill; Xiaoxiao Kong; Russell P Tracy; Eric Boerwinkle; Jerome I Rotter; David-Alexandre Trégouët; Daan W Loth
Journal:  Genet Epidemiol       Date:  2013-05-05       Impact factor: 2.135

Review 3.  Endovascular Therapy for Lower Extremity Chronic Deep Venous Occlusive Disease: State of Practice.

Authors:  Vibhor Wadhwa; Ravi N Srinivasa; Kyle J Cooper; Anthony N Hage; Jacob J Bundy; Brooke Spencer; Venu Vadlamudi; Jeffrey Forris Beecham Chick
Journal:  Semin Intervent Radiol       Date:  2018-11-05       Impact factor: 1.513

4.  Non-O blood group: an important genetic risk factor for venous thromboembolism.

Authors:  Massimo Franchini; Mike Makris
Journal:  Blood Transfus       Date:  2012-10-11       Impact factor: 3.443

5.  Autoimmune diseases and venous thromboembolism: a review of the literature.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

6.  Learning to predict post-hospitalization VTE risk from EHR data.

Authors:  Emily Kawaler; Alexander Cobian; Peggy Peissig; Deanna Cross; Steve Yale; Mark Craven
Journal:  AMIA Annu Symp Proc       Date:  2012-11-03

7.  Futility of testing for factor V Leiden.

Authors:  Emmanuel J Favaloro; David McDonald
Journal:  Blood Transfus       Date:  2012-07       Impact factor: 3.443

Review 8.  Utility of testing for factor V Leiden.

Authors:  Massimo Franchini
Journal:  Blood Transfus       Date:  2012-07       Impact factor: 3.443

9.  Factor V Leiden, prothrombin 20210G>A, MTHFR 677C>T and 1298A>C, and homocysteinemia in Tunisian blood donors.

Authors:  Samira Hadhri; Mohamed Ben Rejab; Hajer Guedria; Lamia Ifa; Noureddine Chatti; Hadef Skouri
Journal:  J Clin Lab Anal       Date:  2012-05       Impact factor: 2.352

10.  Combined Thrombophilia in a Young Male Presenting as Life Threatening Pulmonary Embolism.

Authors:  Akshyaya Pradhan; Ayush Shukla; Mili Jain; Anupam Mehrotra; Rishi Sethi
Journal:  J Clin Diagn Res       Date:  2017-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.